Skip to main content
. 2021 Sep 13;11:723345. doi: 10.3389/fonc.2021.723345

Figure 4.

Figure 4

Normalized feature importance. (A–C) Feature importance in predicting LNMs for all validation patients and patients with/without metastases. (D–I) Feature importance in predicting the N stage for all validation patients and patients with five N stages (N0, N1, N2, N3a, and N3b).